Physician profile
Dana L Raspberry
NPI 1730204900
$1,033.29
in general payments reported to CMS, 2019-2025
12 companies · $283 in 2025
The $283 reported for 2025 was more than what 82% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $39.59 · 2021: $101 · 2022: $51.40 · 2023: $132 · 2024: $306 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $246.33 | 2021-2025 | Invisalign |
| Dentsply Sirona INC | $127.32 | 2019-2025 | Implant Dentistry, Cerec, Atlantis |
| Solventum Corporation | $124.07 | 2024-2025 | 3m Relyx, 3m Scotchbond, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Nobel Biocare USA | $118.18 | 2023 | Nobelactive |
| Straumann USA LLC | $107.29 | 2025 | |
| Dentsply LLC | $98.15 | 2019 | |
| Henry Schein, INC. | $91.68 | 2024 | |
| Zest Holdings, LLC | $44.50 | 2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $27.76 | 2021 | |
| Biolase, INC. | $21.50 | 2021 | |
| 3m Company | $14.05 | 2023 | Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative, Clarity Aligners |
| Ivoclar Vivadent, INC. | $12.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Raspberry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.